- Events
17/04/2025
TransCure BioServices is thrilled to announce our participation in the upcoming EASL Congress 2024, a leading event dedicated to liver research. Join us in Milan for this pivotal gathering, where the brightest minds in hepatology convene to share their latest findings, innovative research methods, and forward-thinking treatments.
At EASL 2024, TransCure BioServices will be at the forefront, contributing to the dynamic discussions and groundbreaking research presentations. We are committed to enhancing liver disease research through our advanced humanized mouse models, offering new insights into the complexities of liver disorders.
Our presence at EASL underscores our dedication to combatting liver diseases and our continuous effort to support the hepatology community by providing robust preclinical research platforms. We look forward to engaging with fellow researchers, clinicians, and industry professionals to explore new possibilities in liver health, discuss challenges, and uncover solutions that will shape the future of hepatology.
This year, we are excited to have our Business Developer, Ha-Yeon Kim-Penard, PhD, and our Head of Research and Development, Emilie Bayon, PhD, in attendance. Both are eager to exchange ideas, discuss our latest research findings, and explore potential collaborations. Ha-Yeon and Emilie bring a wealth of knowledge and expertise in preclinical research and are looking forward to connecting with attendees to discuss how TransCure’s innovative solutions can support and advance your preclinical research projects.
For more information about our participation in EASL and how TransCure BioServices is contributing to advancements in liver disease research, please contact us.
We can’t wait to meet you in Milan for a week of inspirational scientific exchange and progress in the field of hepatology.
See you at EASL 2024!